Ngā hua rapu kaituhi

1

Exciting news from Clinical Proteomics mā Chan, Daniel W

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

Proteomic cancer biomarkers from discovery to approval: it’s worth the effort mā Li, Danni, Chan, Daniel W

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers mā Zhang, Zhen, Chan, Daniel W.

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

Aberrant glycosylation associated with enzymes as cancer biomarkers mā Meany, Danni L, Chan, Daniel W

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

The Use of Laser Capture Microscopy in Proteomics Research – A Review mā Kunz, George M., Chan, Daniel W.

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

Enzymes and Related Proteins as Cancer Biomarkers: a Proteomic Approach mā Liang, Shu-Ling, Chan, Daniel W.

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

Biomarkers in prostate cancer: what’s new? mā Sartori, David A., Chan, Daniel W.

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

Precision medicine: from pharmacogenomics to pharmacoproteomics mā Chambliss, Allison B., Chan, Daniel W.

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

Cancer biomarker discovery and translation: proteomics and beyond mā Hristova, Ventzislava A., Chan, Daniel W.

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

Advancing Cardiovascular Biology and Medicine via Proteomics: Opportunities and present challenges of cardiovascular proteomics mā Ping, Peipei, Chan, Daniel W., Srinivas, Pothur

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

Early Detection of Cancer: Immunoassays for Plasma Tumor Markers mā Meany, Danni L., Sokoll, Lori J., Chan, Daniel W.

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
12

Analysis of serum protein glycosylation by a differential lectin immunosorbant assay (dLISA) mā Li, Danni, Chiu, Hanching, Zhang, Hui, Chan, Daniel W

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
13

Validation of a multiplex immunoassay for serum angiogenic factors as biomarkers for aggressive prostate cancer mā Li, Danni, Chiu, Hanching, Gupta, Vinita, Chan, Daniel W.

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
14

Proteomic analysis of degradation ubiquitin signaling by ubiquitin occupancy changes responding to 26S proteasome inhibition mā Hristova, Ventzislava, Sun, Shisheng, Zhang, Hui, Chan, Daniel W.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
15

Correction to: Proteomic analysis of degradation ubiquitin signaling by ubiquitin occupancy changes responding to 26S proteasome inhibition mā Hristova, Ventzislava, Sun, Shisheng, Zhang, Hui, Chan, Daniel W.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
16

Suppression of Annexin A11 in Ovarian Cancer: Implications in Chemoresistance mā Song, Jin, Shih, Ie-Ming, Chan, Daniel W, Zhang, Zhen

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
17

Tyramide Signal Amplification for Antibody-overlay Lectin Microarray: A Strategy to Improve the Sensitivity of Targeted Glycan Profiling mā Meany, Danni L., Hackler, Laszlo, Zhang, Hui, Chan, Daniel W.

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
18

Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays mā Song, Jin, Sokoll, Lori J., Chan, Daniel W., Zhang, Zhen

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
19

Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges mā Füzéry, Anna K, Levin, Joshua, Chan, Maria M, Chan, Daniel W

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
20

Integrated Analyses of Proteins and Their Glycans in a Magnetic Bead–Based Multiplex Assay Format mā Li, Danni, Chiu, Hanching, Chen, Jing, Zhang, Hui, Chan, Daniel W.

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Chan, Daniel W

Exciting news from Clinical Proteomics mā Chan, Daniel W

Proteomic cancer biomarkers from discovery to approval: it’s worth the effort mā Li, Danni, Chan, Daniel W

The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers mā Zhang, Zhen, Chan, Daniel W.

Aberrant glycosylation associated with enzymes as cancer biomarkers mā Meany, Danni L, Chan, Daniel W

The Use of Laser Capture Microscopy in Proteomics Research – A Review mā Kunz, George M., Chan, Daniel W.

Enzymes and Related Proteins as Cancer Biomarkers: a Proteomic Approach mā Liang, Shu-Ling, Chan, Daniel W.

Biomarkers in prostate cancer: what’s new? mā Sartori, David A., Chan, Daniel W.

Precision medicine: from pharmacogenomics to pharmacoproteomics mā Chambliss, Allison B., Chan, Daniel W.

Cancer biomarker discovery and translation: proteomics and beyond mā Hristova, Ventzislava A., Chan, Daniel W.

Advancing Cardiovascular Biology and Medicine via Proteomics: Opportunities and present challenges of cardiovascular proteomics mā Ping, Peipei, Chan, Daniel W., Srinivas, Pothur

Early Detection of Cancer: Immunoassays for Plasma Tumor Markers mā Meany, Danni L., Sokoll, Lori J., Chan, Daniel W.

Analysis of serum protein glycosylation by a differential lectin immunosorbant assay (dLISA) mā Li, Danni, Chiu, Hanching, Zhang, Hui, Chan, Daniel W

Validation of a multiplex immunoassay for serum angiogenic factors as biomarkers for aggressive prostate cancer mā Li, Danni, Chiu, Hanching, Gupta, Vinita, Chan, Daniel W.

Proteomic analysis of degradation ubiquitin signaling by ubiquitin occupancy changes responding to 26S proteasome inhibition mā Hristova, Ventzislava, Sun, Shisheng, Zhang, Hui, Chan, Daniel W.

Correction to: Proteomic analysis of degradation ubiquitin signaling by ubiquitin occupancy changes responding to 26S proteasome inhibition mā Hristova, Ventzislava, Sun, Shisheng, Zhang, Hui, Chan, Daniel W.

Suppression of Annexin A11 in Ovarian Cancer: Implications in Chemoresistance mā Song, Jin, Shih, Ie-Ming, Chan, Daniel W, Zhang, Zhen

Tyramide Signal Amplification for Antibody-overlay Lectin Microarray: A Strategy to Improve the Sensitivity of Targeted Glycan Profiling mā Meany, Danni L., Hackler, Laszlo, Zhang, Hui, Chan, Daniel W.

Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays mā Song, Jin, Sokoll, Lori J., Chan, Daniel W., Zhang, Zhen

Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges mā Füzéry, Anna K, Levin, Joshua, Chan, Maria M, Chan, Daniel W

Integrated Analyses of Proteins and Their Glycans in a Magnetic Bead–Based Multiplex Assay Format mā Li, Danni, Chiu, Hanching, Chen, Jing, Zhang, Hui, Chan, Daniel W.

Ngā utauta rapu: